Skip to content

Study on a prediction model of the gastric residual volume threshold causing aspiration in nasogastric tube feeding NICU patients.

Study on a prediction model of the gastric residual volume threshold causing aspiration in nasogastric tube feeding NICU patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075502
Enrollment
Unknown
Registered
2023-09-06
Start date
2023-09-15
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aspiration

Interventions

control group:Patients' threshold of gastric residual volume is 200mL. When patients' gastric residual volume reaches 200mL, give gastric motility drugs and discard excess gastric contents. The discar
experimental group:Patients' threshold of gastric residual volume is calculated from the prediction model of the gastric residual volume threshold causing aspiration. When patients' gastric residual v

Sponsors

Xuanwu Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 110 Years

Inclusion criteria

Inclusion criteria: ?Patients admitted to the Neurosurgical intensive care Unit of Xuanwu Hospital, Intensive Care Unit 2, Intensive Care Unit 3 and neurological intensive Care Unit of Tiantan Hospital during the recruiting period. ?Nasogastric tube is used to achieve enteral nutrition. ?Establish an artificial airway and use a ventilator. ?At least 18 years old.

Exclusion criteria

Exclusion criteria: ? Enteral nutrition was started before admission to the neurosurgical ICU; ? Patients with severe heart dysfunction, severe liver and kidney dysfunction, severe endocrine diseases, organic diseases of gastrointestinal system, end-stage multiple organ failure; ? Patients after gastrointestinal surgery within the last three months; ? Patients with previous gastroesophageal reflux disease or dysphagia; ? Patients who had received gastrointestinal motility drugs before included in the trial; ? Patients or family members refused to participate in the trial.

Design outcomes

Primary

MeasureTime frame
aspiration rate;

Secondary

MeasureTime frame
vomit rate;diarrhea rate;

Countries

China

Contacts

Public ContactJun Wang

Xuanwu Hospital Capital Medical University

wangj229@126.com+86 186 1258 3695

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026